Neurotherapeutics Symposium 2022: Integrating Equity within Translational Research

2022 年神经治疗研讨会:将公平纳入转化研究

基本信息

  • 批准号:
    10391768
  • 负责人:
  • 金额:
    $ 2.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-12-15 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Life-changing and curative therapies for disabling and fatal neurological conditions are costly and often inaccessible for patients from underrepresented minority (URM) populations. During trans- lational research in neurology, much of this inaccessibility begins at the therapy development phase and grows through the implementation and dissemination phases. There is, therefore, a critical need to widely educate the neurology workforce on the importance of integrating an equity focus within translational research in neurology, with the ultimate goal of accelerating the transla- tion of advances in neurological therapy into improved health outcomes for all patients. As the first virtual conference dedicated to address this problem, the “Neurotherapeutics Symposium 2022: Integrating Equity within Translational Research”, will achieve the following aims: 1) dis- seminate knowledge on existing inequities and ongoing efforts to integrate equity within transla- tional research in neurology, 2) facilitate the integration of an equity focus within ongoing and future translational research efforts of symposium participants, and 3) assess the extent to which participants knowledge on existing inequities and ongoing efforts to integrate equity within trans- lational research in neurology has increased. During online registration, an electronic survey of 10 multiple-choice questions will assess pre-conference knowledge on 1) existing inequities dur- ing translational research in neurology and 2) ongoing efforts to integrate equity within transla- tional research in neurology. Registered participants, particularly trainees and early-career inves- tigators, will be encouraged to submit abstracts to present their research. Abstracts will include an “equity focus” to emphasize the importance of this topic for the conference. During the sympo- sium, experts in the field will deliver 10 virtual lectures and will participate in four panels using stroke, multiple sclerosis and Parkinson’s disease as examples to illustrate the topics of the con- ference. Three mentoring group sessions and a virtual poster presentation session will facilitate discussion, development and expansion of the “equity focus” described in submitted abstracts. Six months after the symposium, the same electronic survey will measure change from pre-con- ference knowledge. The expected outcomes of this conference is that up to 150 participants will have increased their knowledge and integrated an equity focus within their ongoing and future translational research efforts in neurology.
项目摘要 改变生活和治愈性治疗致残和致命的神经系统疾病是昂贵的, 来自代表性不足的少数群体(URM)的患者通常无法获得。在跨- 在神经病学的国际研究中,这种不可及性大多始于治疗的发展。 阶段并在实施和传播阶段不断发展。因此,有一个 迫切需要广泛教育神经病学工作人员,使其了解将公平 专注于神经病学的转化研究,最终目标是加速翻译, 将神经治疗的进步转化为改善所有患者的健康结果。为 第一个致力于解决这个问题的虚拟会议,“神经治疗研讨会 2022年:将平等融入转化研究”,将实现以下目标:1) 传播关于现有不平等现象的知识,并不断努力将平等纳入跨性别平等, 在神经病学的传统研究,2)促进公平的重点, 研讨会参与者未来的翻译研究工作,以及3)评估在多大程度上, 参与者了解现有的不平等现象和正在进行的将公平纳入跨部门工作的努力, 神经病学的国家研究有所增加。在网上登记时, 10个多项选择题将评估会前知识:1)现有的不平等, 在神经病学的转化研究和2)正在进行的努力,以整合平等内transla, 神经病学的理论研究注册参与者,特别是受训人员和早期职业投资者- 将被鼓励提交摘要来介绍他们的研究。摘要将包括 “注重公平”,以强调这一专题对会议的重要性。在症状- 该领域的专家将提供10个虚拟讲座,并将参加四个小组, 中风,多发性硬化症和帕金森氏病的例子,以说明主题的con... 请原谅。三个指导小组会议和一个虚拟海报展示会议将促进 讨论、发展和扩大提交的摘要中所述的“公平重点”。 研讨会后六个月,同样的电子调查将衡量从前CON的变化, 参考知识。本次会议的预期成果是,多达150名与会者将 增加了他们的知识,并将公平重点纳入他们的持续和未来 神经学的转化研究成果。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karlo J. Lizarraga其他文献

Hyperglycemic hemichorea presenting with normal MRI and striatal hyperdensity on CT
  • DOI:
    10.1007/s10072-021-05433-6
  • 发表时间:
    2021-06-29
  • 期刊:
  • 影响因子:
    2.400
  • 作者:
    Natalia Chunga;Anthony E. Lang;Karlo J. Lizarraga
  • 通讯作者:
    Karlo J. Lizarraga
Management of Pisa syndrome with lateralized subthalamic stimulation
  • DOI:
    10.1007/s00415-018-8991-8
  • 发表时间:
    2018-08-03
  • 期刊:
  • 影响因子:
    4.600
  • 作者:
    Karlo J. Lizarraga;Maryam Naghibzadeh;Alexandre Boutet;Gavin J. B. Elias;Alfonso Fasano
  • 通讯作者:
    Alfonso Fasano

Karlo J. Lizarraga的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 2.55万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 2.55万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 2.55万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 2.55万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 2.55万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 2.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了